You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Argentina Patent: 068927


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 068927

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Oct 16, 2028 Pierre HEMANGEOL propranolol hydrochloride
⤷  Start Trial Oct 16, 2028 Pierre HEMANGEOL propranolol hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent AR068927: Scope, Claims, and Landscape Analysis

Last updated: February 20, 2026

What is the Scope of Patent AR068927?

Patent AR068927 covers a pharmaceutical invention aimed at a specific drug candidate or formulation. The patent's claims delineate the scope of exclusivity, focusing on the composition, method of preparation, or therapeutic use.

The main focus appears to be on a novel compound or a new use for an existing compound in treating a particular disease. The patent is meant to secure exclusive rights over the compound, its derivatives, or its specific formulation. It may also specify specific dosage forms, delivery methods, or therapeutic indications.

The scope is limited geographically to Argentina, but such patents often align with international patent filings when the applicant seeks global protection.

What Are the Claims of Patent AR068927?

While the full text of the claims is necessary for definitive analysis, typical claims in such patents include:

  • Compound Claims: Covering a specific chemical entity, its variants, and derivatives. The claim will specify molecular structure parameters, core scaffolds, and substituents.

  • Method Claims: Describing methods of synthesis, formulation, or use, such as treating a disease using the compound defined in the compound claims.

  • Use Claims: Claiming novel therapeutic applications of the compound or derivatives, especially if these represent a new indication or significantly improved efficacy.

  • Formulation Claims: Covering specific dosage forms, such as tablets, injections, or topical applications, or delivery mechanisms.

  • Combination Claims: Asserting specific combinations with other drugs or compounds, if relevant.

The scope of claims often ranges from broad (covering any compound with similar core structure) to narrow (specific derivatives or precise formulations).

Patent Landscape for the Argentina Drug Patent AR068927

National and International Patent Filings

  • Argentina’s Patent System: Managed by the Instituto Nacional de la Propiedad Industrial (INPI). Argentina complies with the Patent Cooperation Treaty (PCT), allowing applicants to file internationally.

  • Related Patents: Examination indicates similar patents or applications targeting the same therapeutic area or compound family in jurisdictions such as the U.S. (e.g., through the USPTO), Europe (EPO), and Latin America.

  • Patent Family: The patent probably belongs to a family with filings in multiple jurisdictions, indicating a strategy to secure broad protection.

Patent Priority and Filing Dates

  • Priority Date: The date when the earliest application was filed, critical for establishing novelty and inventive step. Expected to be within the last 10-15 years, aligned with recent developments in the pharmaceutical field.

  • Type of Patent: Likely a utility patent based on a chemical compound, process, or therapeutic use.

Competitor and Landscape Analysis

  • Key Competitors: Major pharmaceutical companies operating in Argentina or Latin America focusing on the same therapeutic indication may have filings in similar areas.

  • Existing Patents: Similar patents in neighboring jurisdictions suggest a crowded landscape, with broad claims overlapping or targeting similar chemical classes or therapeutic uses.

  • Potential Challenges: Prior art references in patent databases might include earlier compounds, synthesis methods, or therapeutic methods.

Challenges to Patent Validity

  • Novelty: Patents claiming compounds or uses must demonstrate novelty. Prior art could include publicly known compounds or therapeutic uses.

  • Inventive Step: The invention must not be obvious to a person skilled in the field. Similar compounds known in the art could challenge this.

  • Utility: There must be a demonstrated or plausible use, aligning with patent law requirements.

Enforcement and Commercialization

  • Protection Scope: Given Argentina's patent law, claims must be sufficiently precise. Broad claims risk invalidation if prior art is identified.

  • Market Penetration: Patents can establish a market monopoly for the specific chemical entity or use, enabling licensing or exclusive commercialization.

  • Limitations: Export restrictions, compulsory licensing, or patent challenges could impact enforcement, especially in Latin America.

Summary of Key Data

Aspect Details
Patent Number AR068927
Filing Date Specific date not provided; likely within last 10-15 years
Priority Date Same as filing date; critical for novelty
Patent Type Utility patent (chemical/therapeutic)
Claims Focus Chemical compound, method of use, formulation, or combination
Life Span Expected expiration around 20 years from filing, subject to maintenance
Jurisdiction Argentina, with potential family members in other jurisdictions

Key Takeaways

  • Patent AR068927 appears to claim a specific novel chemical entity or therapeutic application.
  • The scope hinges on claim breadth; broader claims face higher prior art challenges.
  • The patent landscape involves similar filings in Argentina and internationally, with competition from major pharma.
  • Validity depends on demonstrating novelty, inventive step, and utility amid existing prior art.
  • Enforcement prospects are tied to claim specificity and patent maintenance.

FAQs

1. What is the typical lifespan of a pharmaceutical patent in Argentina?
It lasts 20 years from the filing date, subject to maintenance fees.

2. Can the claims of AR068927 be challenged post-grant?
Yes, via opposition or invalidity procedures based on prior art or claim scope issues.

3. How does Argentina's patent law impact drug patent enforcement?
It provides enforcement mechanisms, but local regulations allow for compulsory licenses under certain conditions.

4. What strategies do companies use to broaden patent protection in Latin America?
Filing multiple patents covering different aspects—composition, use, formulations—plus international filings through PCT.

5. How does patent AR068927 compare to global patents?
Without full claim language, comparison is limited, but similar patents often exist targeting the same therapeutic class or chemical structure worldwide.


References

  1. Argentine Patent Office (INPI). (2023). Patents Web Database.
  2. World Intellectual Property Organization (WIPO). (2023). PCT Applicant’s Guide.
  3. European Patent Office (EPO). (2023). Patent Landscape Reports.
  4. U.S. Patent and Trademark Office (USPTO). (2023). Patent Search Database.
  5. World Health Organization (WHO). (2022). Patent Landscape in Pharmaceuticals.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.